Apple announces Watch Series 4 with 40mm and 44mm displays, a larger focus on health data, 2x faster 64-bit Dual Core processor, watchOS 5, and more for $399+
Heavily rumored since shortly after the release of its predecessor, and accidentally revealed in pre-event leaks of images and basic specs …
Context & Ripple Effects
The Series 4 is the reset point for the Apple Watch line: the 40mm/44mm sizing, the $399 entry price, and the pivot from notifications to health data all debut here, after months of leaks had already exposed the redesign. Every subsequent model in the coverage builds on this frame — the Watch SE is explicitly described as carrying a 'Series 4-type design', and the flagship line holds the $399 anchor through Series 6, 7, 8, and 9.
What changes over time is what sits inside that frame: the health-data emphasis announced here escalates into a blood oxygen sensor in Series 6 and a body-temperature sensor aimed at women's health in the Series 8, while the 2022 Watch Ultra opens a $799 athletic tier above the mainstream line.
First-order effects
- Buyers get roughly double the performance and visibly larger displays at the same $399+ entry price the line has kept since earlier generations, with watchOS 5 shipping alongside.
Second-order effects
- The larger-display, health-first template becomes cheap enough to cascade downmarket — two years later Apple reuses the Series 4 industrial design in the $279 SE, splitting the lineup into a budget tier and a sensor-rich flagship tier.
Third-order effects
- If the pattern holds, the smartwatch market consolidates around an annual health-sensor cadence rather than raw spec bumps, with Apple defending a fixed $399 anchor while premium variants like the Ultra absorb buyers willing to pay for durability and battery life.
The trend: Smartwatch competition is shifting from processor and display specs to proprietary health sensing, with Apple anchoring the mainstream price point while layering premium tiers on top.